Skip to main content
Top
Published in: European Journal of Nutrition 2/2010

01-03-2010 | Original Contribution

Potential antitumor properties of a protein isolate obtained from the seeds of Amaranthus mantegazzianus

Authors: Daniel Alejandro Barrio, María Cristina Añón

Published in: European Journal of Nutrition | Issue 2/2010

Login to get access

Abstract

Background

Amaranth is a crop that can be grown in different soils and climates, being resistant to high temperatures, drought, and some pests. The amaranth plant has nutritional qualities and desirable biological properties.

Aim of the study

The aim of the study is to investigate the potential antitumor properties of Amaranthus-mantegazzianus-protein isolate (MPI) and to elucidate the possible mechanism of action.

Methods

We use four different tumor-derived and in vitro-transformed cell lines with different morphology and tumorigenicity (MC3T3E1, UMR106, Caco-2, and TC7).

Results

The MPI showed an antiproliferative effect on four cell lines with different potencies. The tumor-cell line UMR106 was the most sensitive (IC50: 1 mg/ml). This antiproliferative effect of the MPI was enhanced by protease treatment (IC50: 0.5 after 30% hydrolysis). In addition, the MPI produced morphological changes and caused a rearrangement of the cytoskeleton in UMR106 cell line. In an attempt to elucidate the mechanism of action, we observed that the MPI inhibited cell adhesion and induced apoptosis and necrosis in the UMR106 cell line. In reversibility studies, we were able to observe both temporary and permanent cytostatic and cytotoxic effects on the part of the MPI, depending on its concentration.

Conclusions

we report a protein isolate from the seeds of Amaranthus mantegazzianus that exhibit potential antitumor properties and propose a putative mechanism of action.
Literature
1.
go back to reference Adlercreutz H (1998) Epidemiology of phytoestrogens. Baillieres Clin Endocrinol Metab 12:605–623CrossRef Adlercreutz H (1998) Epidemiology of phytoestrogens. Baillieres Clin Endocrinol Metab 12:605–623CrossRef
2.
go back to reference Adler-Nissen J (1979) Determination of degree of hydrolysis of food protein hydrolysates by trinitrobenzenesulfonic acid. J Agric Food Chem 27:1256–1262CrossRef Adler-Nissen J (1979) Determination of degree of hydrolysis of food protein hydrolysates by trinitrobenzenesulfonic acid. J Agric Food Chem 27:1256–1262CrossRef
3.
go back to reference Ailenberg M, Silverman M (2003) Cytochalasin D disruption of actin filaments in 3T3 cells produces an anti-apoptotic response by activating gelatinase A extracellularly and initiating intracellular survival signals. Biochim Biophys Acta 1593:249–258CrossRef Ailenberg M, Silverman M (2003) Cytochalasin D disruption of actin filaments in 3T3 cells produces an anti-apoptotic response by activating gelatinase A extracellularly and initiating intracellular survival signals. Biochim Biophys Acta 1593:249–258CrossRef
4.
go back to reference Aphalo P, Castellani OF, Martinez EN, Añon MC (2004) Surface physicochemical properties of globulin-P amaranth protein. J Agric Food Chem 52:616–622CrossRef Aphalo P, Castellani OF, Martinez EN, Añon MC (2004) Surface physicochemical properties of globulin-P amaranth protein. J Agric Food Chem 52:616–622CrossRef
5.
go back to reference Barba de la Rosa AP, Silva-Sanchez C, González de Mejia E (2007) Amaranth: an ancient crop for modern technology. In: Tunick MH, Gonzalez De Mejia E (eds) Hispanic foods: chemistry and flavor. American Chemical Society, Washington, DC, pp 103–116 Barba de la Rosa AP, Silva-Sanchez C, González de Mejia E (2007) Amaranth: an ancient crop for modern technology. In: Tunick MH, Gonzalez De Mejia E (eds) Hispanic foods: chemistry and flavor. American Chemical Society, Washington, DC, pp 103–116
6.
go back to reference Becker R, Wheeler E, Lorenz K, Stafford A, Grosjean O, Betschart A, Saunders RA (1981) Compositional study of amaranth grain. J Food Sci 46:1175–1180CrossRef Becker R, Wheeler E, Lorenz K, Stafford A, Grosjean O, Betschart A, Saunders RA (1981) Compositional study of amaranth grain. J Food Sci 46:1175–1180CrossRef
7.
go back to reference Bressani R (1989) The proteins of grain amaranth food. Rev Inter 5:13–38 Bressani R (1989) The proteins of grain amaranth food. Rev Inter 5:13–38
8.
go back to reference Chagolla-Lopez A, Blanco-Labra A, Patthy A, Sanchez R, Pongor S (1994) A novel alpha-amylase inhibitor from amaranth (Amaranthus hypocondriacus) seeds. J Biol Chem 38:23675–23680 Chagolla-Lopez A, Blanco-Labra A, Patthy A, Sanchez R, Pongor S (1994) A novel alpha-amylase inhibitor from amaranth (Amaranthus hypocondriacus) seeds. J Biol Chem 38:23675–23680
9.
go back to reference Clare DA, Swaisgood HE (2000) Bioactive milk peptides: a prospectus. J Dairy Sci 83:1187–1195CrossRef Clare DA, Swaisgood HE (2000) Bioactive milk peptides: a prospectus. J Dairy Sci 83:1187–1195CrossRef
10.
go back to reference Correa P, Miller MJ (1998) Carcinogenesis apoptosis and cell proliferation. Br Med Bull 54:151–162 Correa P, Miller MJ (1998) Carcinogenesis apoptosis and cell proliferation. Br Med Bull 54:151–162
11.
go back to reference Correa AD, Jokl L, Carlsson R (1986) Amino acid composition of some Amaranthus sp. grain proteins and of its fractions. Arch Latinoam Nutr 3:466–476 Correa AD, Jokl L, Carlsson R (1986) Amino acid composition of some Amaranthus sp. grain proteins and of its fractions. Arch Latinoam Nutr 3:466–476
12.
go back to reference Danen EH (2005) Integrins: regulators of tissue function and cancer progression. Curr Pharm 11:881–891CrossRef Danen EH (2005) Integrins: regulators of tissue function and cancer progression. Curr Pharm 11:881–891CrossRef
13.
go back to reference De Bolle MF, David KM, Rees B, Vanderleyden J, Cammue BP, Broekaert WF (1993) Cloning and characterization of a cDNA encoding an antimicrobial chitin-binding protein from amaranth Amaranthus caudatus. Plant Mol Biol 6:1187–1190CrossRef De Bolle MF, David KM, Rees B, Vanderleyden J, Cammue BP, Broekaert WF (1993) Cloning and characterization of a cDNA encoding an antimicrobial chitin-binding protein from amaranth Amaranthus caudatus. Plant Mol Biol 6:1187–1190CrossRef
14.
go back to reference Ducy P, Schinke T, Karsenty (2000) The osteoblast: a sophisticated fibroblast under central surveillance. Science 289:1501–1504CrossRef Ducy P, Schinke T, Karsenty (2000) The osteoblast: a sophisticated fibroblast under central surveillance. Science 289:1501–1504CrossRef
15.
go back to reference Galvez AF, Chen N, Macasieb J, de Lumen BO (2001) Chemopreventive property of a soybean peptide (Lunasin) that binds to deacetylated histones and inhibits acetylation. Cancer Res 61:7473–7478 Galvez AF, Chen N, Macasieb J, de Lumen BO (2001) Chemopreventive property of a soybean peptide (Lunasin) that binds to deacetylated histones and inhibits acetylation. Cancer Res 61:7473–7478
16.
go back to reference Janmey PA (1998) The cytoskeleton and cell signaling: component localization and mechanical coupling. Physiol Rev 78:763–781 Janmey PA (1998) The cytoskeleton and cell signaling: component localization and mechanical coupling. Physiol Rev 78:763–781
17.
go back to reference Jayaprakasam B, Zhang Y, Nair MG (2004) Tumor cell proliferation and cyclooxygenase enzyme inhibitory compounds in Amaranthus tricolor. Agric Food Chem 52:6939–6943CrossRef Jayaprakasam B, Zhang Y, Nair MG (2004) Tumor cell proliferation and cyclooxygenase enzyme inhibitory compounds in Amaranthus tricolor. Agric Food Chem 52:6939–6943CrossRef
18.
go back to reference Jeong J, Park JH, Lam Y, de Lumen BO (2003) Characterization of lunasin isolated from soybean. J Agric Food Chem 7:7901–7906CrossRef Jeong J, Park JH, Lam Y, de Lumen BO (2003) Characterization of lunasin isolated from soybean. J Agric Food Chem 7:7901–7906CrossRef
19.
go back to reference Kelloff GJ, Crowell JA, Steele VE, Lubet RA, Malone WA, Boone CW, Kopelovich L, Hawk ET, Lieberman R, Lawrence JA, Ali I, Viner JL, Sigman CC (2000) Progress in cancer chemoprevention: development of diet-derived chemopreventive agents. J Nutr 130:467S–471S Kelloff GJ, Crowell JA, Steele VE, Lubet RA, Malone WA, Boone CW, Kopelovich L, Hawk ET, Lieberman R, Lawrence JA, Ali I, Viner JL, Sigman CC (2000) Progress in cancer chemoprevention: development of diet-derived chemopreventive agents. J Nutr 130:467S–471S
20.
go back to reference Kim SE, Kim HH, Kim JY, Kang I, Woo HJ, Lee HJ (2000) Anticancer activity of hydrophobic peptides from soy proteins. Biofactors 1–4:151–155CrossRef Kim SE, Kim HH, Kim JY, Kang I, Woo HJ, Lee HJ (2000) Anticancer activity of hydrophobic peptides from soy proteins. Biofactors 1–4:151–155CrossRef
21.
go back to reference Kuzelová K, Grebenová D, Pluskalová M, Marinov I, Hrkal Z (2004) Early apoptotic features of K562 cell death induced by 5-aminolaevulinic acid-based photodynamic therapy. J Photochem Photobiol B 1–2:67–78CrossRef Kuzelová K, Grebenová D, Pluskalová M, Marinov I, Hrkal Z (2004) Early apoptotic features of K562 cell death induced by 5-aminolaevulinic acid-based photodynamic therapy. J Photochem Photobiol B 1–2:67–78CrossRef
22.
go back to reference Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685CrossRef Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685CrossRef
23.
go back to reference Lash LH, Tokarz JJ, Pegouske DM (1995) Susceptibility of primary cultures of proximal tubular and distal tubular cells from rat kidney to chemically induced toxicity. Toxicology 103:85–103CrossRef Lash LH, Tokarz JJ, Pegouske DM (1995) Susceptibility of primary cultures of proximal tubular and distal tubular cells from rat kidney to chemically induced toxicity. Toxicology 103:85–103CrossRef
24.
go back to reference Lipkin A, Anisimova V, Nikonorova A, Babakov A, Krause E, Bienert M, Grishin E, Egorov T (2005) An antimicrobial peptide Ar-AMP from amaranth (Amaranthus retroflexus L.) seeds. Phytochemistry 20:2426–2431CrossRef Lipkin A, Anisimova V, Nikonorova A, Babakov A, Krause E, Bienert M, Grishin E, Egorov T (2005) An antimicrobial peptide Ar-AMP from amaranth (Amaranthus retroflexus L.) seeds. Phytochemistry 20:2426–2431CrossRef
25.
go back to reference Liu YK, Nemoto A, Feng Y, Uemura T (1997) The binding ability to matrix proteins and the inhibitory effects on cell adhesion of synthetic peptides derived from a conserved sequence of integrins. J Biochem 121:961–968 Liu YK, Nemoto A, Feng Y, Uemura T (1997) The binding ability to matrix proteins and the inhibitory effects on cell adhesion of synthetic peptides derived from a conserved sequence of integrins. J Biochem 121:961–968
26.
go back to reference Lokich J, Anderson N, Moore C, Bern M, Coco F, Sonneborn H, Dow E, Strong D (1998) Paclitaxel cisplatin and etoposide combination chemotherapy: a comparison of dose intensity in two multifractionated dose schemas. Eur J Cancer 34:664–667CrossRef Lokich J, Anderson N, Moore C, Bern M, Coco F, Sonneborn H, Dow E, Strong D (1998) Paclitaxel cisplatin and etoposide combination chemotherapy: a comparison of dose intensity in two multifractionated dose schemas. Eur J Cancer 34:664–667CrossRef
27.
go back to reference Martínez EN, Añón MC (1996) Composition and structural characterization of amaranth protein isolates an electrophoretic and calorimetric study. J Agric Food Chem 44:2523–2530CrossRef Martínez EN, Añón MC (1996) Composition and structural characterization of amaranth protein isolates an electrophoretic and calorimetric study. J Agric Food Chem 44:2523–2530CrossRef
28.
go back to reference Martínez EN, Castellani OF, Añón MC (1997) Common molecular features among amaranth storage proteins. J Agric Food Chem 45:3832–3839CrossRef Martínez EN, Castellani OF, Añón MC (1997) Common molecular features among amaranth storage proteins. J Agric Food Chem 45:3832–3839CrossRef
29.
go back to reference Martins JC, Enassar M, Willem R, Wieruzeski JM, Lippens G, Wodak SJ (2001) Solution structure of the main alpha-amylase inhibitor from amaranth seeds. Eur J Biochem 8:2379–2389CrossRef Martins JC, Enassar M, Willem R, Wieruzeski JM, Lippens G, Wodak SJ (2001) Solution structure of the main alpha-amylase inhibitor from amaranth seeds. Eur J Biochem 8:2379–2389CrossRef
30.
go back to reference McCarty AD, Uemura T, Etcheverry SB, Cortizo AM (2004) Advanced glycation endproducts interfere with integrin-mediated osteoblastic attachment to a type-I collagen matrix. Int J Biochem Cell Biol 36:840–848CrossRef McCarty AD, Uemura T, Etcheverry SB, Cortizo AM (2004) Advanced glycation endproducts interfere with integrin-mediated osteoblastic attachment to a type-I collagen matrix. Int J Biochem Cell Biol 36:840–848CrossRef
31.
go back to reference Morris CA, Morris LD, Kennedy AR, Sweeney HL (2005) Attenuation of skeletal muscle atrophy via protease inhibition. J Appl Physiol 5:1719–1727CrossRef Morris CA, Morris LD, Kennedy AR, Sweeney HL (2005) Attenuation of skeletal muscle atrophy via protease inhibition. J Appl Physiol 5:1719–1727CrossRef
32.
go back to reference Okajima T, Nakamura K, Zhang H, Ling N, Tanabe T, Yasuda T, Rosenfeld RG (1992) Sensitive colorimetric bioassays for insulin-like growth factor (IGF) stimulation of cell proliferation and glucose consumption: use in studies of IGF analogs. Endocrinology 4:2201–2212CrossRef Okajima T, Nakamura K, Zhang H, Ling N, Tanabe T, Yasuda T, Rosenfeld RG (1992) Sensitive colorimetric bioassays for insulin-like growth factor (IGF) stimulation of cell proliferation and glucose consumption: use in studies of IGF analogs. Endocrinology 4:2201–2212CrossRef
33.
go back to reference Petruccelli S, Añón MC (1995) Partial reduction of soy protein isolate disulfide bonds. J Agric Food Chem 43:2001–2004CrossRef Petruccelli S, Añón MC (1995) Partial reduction of soy protein isolate disulfide bonds. J Agric Food Chem 43:2001–2004CrossRef
34.
go back to reference Reed JC (1998) Deregulation of apoptosis in cancer. Cancer J Sci Am Suppl 1:S8–S14 Reed JC (1998) Deregulation of apoptosis in cancer. Cancer J Sci Am Suppl 1:S8–S14
35.
go back to reference Ricci MS, Zong WX (2006) Chemotherapeutic approaches for targeting cell death pathways. Oncologist 4:342–357CrossRef Ricci MS, Zong WX (2006) Chemotherapeutic approaches for targeting cell death pathways. Oncologist 4:342–357CrossRef
36.
go back to reference Rixe O, Fojo T (2007) Is cell death a critical end point for anticancer therapies or is cytostasis sufficient? Clin Cancer Res 24:7280–7287CrossRef Rixe O, Fojo T (2007) Is cell death a critical end point for anticancer therapies or is cytostasis sufficient? Clin Cancer Res 24:7280–7287CrossRef
37.
go back to reference Silva-Sánchez C, Barba De La Rosa AP, León-Galván MF, De Lumen BO, De León-Rodríguez A, González De Mejía E (2008) Bioactive peptides in Amaranth (Amaranthus hypochondriacus) seed. J Agric Food Chem 56:1233–1240CrossRef Silva-Sánchez C, Barba De La Rosa AP, León-Galván MF, De Lumen BO, De León-Rodríguez A, González De Mejía E (2008) Bioactive peptides in Amaranth (Amaranthus hypochondriacus) seed. J Agric Food Chem 56:1233–1240CrossRef
38.
go back to reference Staunton MJ, Gaffney EF (1998) Apoptosis: basic concepts and potential significance in human cancer. Arch Pathol Lab Med 122:310–319 Staunton MJ, Gaffney EF (1998) Apoptosis: basic concepts and potential significance in human cancer. Arch Pathol Lab Med 122:310–319
39.
go back to reference Stossel TP (1989) From signal to pseudopod how cells control cytoplasmic actin assembly. J Biol Chem 5:18261–18264 Stossel TP (1989) From signal to pseudopod how cells control cytoplasmic actin assembly. J Biol Chem 5:18261–18264
Metadata
Title
Potential antitumor properties of a protein isolate obtained from the seeds of Amaranthus mantegazzianus
Authors
Daniel Alejandro Barrio
María Cristina Añón
Publication date
01-03-2010
Publisher
Springer-Verlag
Published in
European Journal of Nutrition / Issue 2/2010
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-009-0051-9

Other articles of this Issue 2/2010

European Journal of Nutrition 2/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.